Our Approach

Syncanica’s focus is to bring novel, cannabinoid-based prescription medicines to patients in areas of serious unmet need and in which our medicines have the potential to make a real difference to their quality of life.

Our Story

Incorporated in 2018 in Davis, California.

Meet the Team

Team of chemists and business development.

 

Mark Mascal, PhD

Founder & CEO

 

Fei Chang, PhD

Founder & Business Development